VFA
CLB icon

Valeo Financial Advisors’s Core Laboratories CLB Stock Holding History

Valeo Financial Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-320
Closed -$5K – 1692
2020
Q3 		$5K Sell
320
-107
-25% -$2.24K ﹤0.01% 1239
2020
Q2 		$9K Buy
427
+297
+228% +$5.32K ﹤0.01% 1308
2020
Q1 		$1K Hold
130
– – ﹤0.01% 1635
2019
Q4 		$5K Hold
130
– – ﹤0.01% 1264
2019
Q3 		$6K Hold
130
– – ﹤0.01% 1147
2019
Q2 		$7K Buy
+130
New +$7.63K ﹤0.01% 1110
2018
Q2 		– Sell
-107
Closed -$12K – 1629
2018
Q1 		$12K Buy
+107
New +$11.8K ﹤0.01% 874

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Valeo Financial Advisors's CLB Position: Q4 2020 in Review

Valeo Financial Advisors sold out of Core Laboratories (CLB) in Q4 2020, closing a stake of 320 shares — an estimated $5K sold.

Valeo Financial Advisors first reported a position in CLB in Q1 2018 and held it in 7 quarters. The position peaked at $12K in Q1 2018. 181 funds tracked by Wall St. Rank hold CLB as of Q4 2020.

  • Valeo Financial Advisors reported no remaining Core Laboratories position as of Q4 2020 after selling out during the quarter.
  • Valeo Financial Advisors sold 320 Core Laboratories shares in Q4 2020, an estimated $5K.
  • Valeo Financial Advisors first reported a position in Core Laboratories in Q1 2018 and held it in 7 quarters.
  • Valeo Financial Advisors's Core Laboratories position peaked at $12K in Q1 2018.
  • 181 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2020.

Based on Valeo Financial Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.